While CSF levels of Gal-3 have been seen to be elevated in AD individuals (52, 53, 98), plasma levels were not significantly increased in individuals with MCI (53), apart from reports in a preliminary study, where Gal-3 serum levels were found to correlate with clinical dementia rating (CDR) stages (54). This evidence concerns the gene LGALS3 and dementia.